Sean Reynolds, DBA

Helping Spine Surgeons Deliver Better Outcomes—Because Cancer & Degenerative Disease Don’t Wait Surgeons treating patients with spinal tumors or degenerative spine conditions face mounting pressure: deliver better outcomes, adopt innovative technologies, and navigate increasingly complex reimbursement and hospital value analysis systems—all while putting the patient first. I’ve spent 10+ years helping them do just that. As a medical device marketing executive, I specialize in upstream and downstream marketing for spinal implants with a deep focus on both oncologic and degenerative applications. From launching next-gen implant systems that enable precise resection and reconstruction, to building KOL-driven strategies that influence payer approval and adoption, I connect the clinical, technical, and commercial dots to bring meaningful solutions to market—and to the OR. Impact by the Numbers: *4x market share growth in a competitive segment within 18 months through integrated surgeon education, rep enablement, and product messaging. *7 successful product launches, including various systems for metastatic spine and posterior cervical constructs for DDD. *Built and scaled KOL networks in both community and academic settings, leading to faster adoption curves and key clinical validation. *Led branding and positioning of a spine portfolio that resulted in significant YoY revenue increases. What sets me apart is the way I lead with clinical empathy and commercial precision. I understand that surgeons don’t just want innovation—they want confidence that the technology will perform under pressure. That it will help their patients walk again, fight another day, or avoid another fusion. My approach combines: *Market-backed voice-of-customer insights *Clinical data storytelling that resonates with payers and providers *Surgeon and sales team alignment at every stage of the product lifecycle On a more personal note, I know that, “What I bring into the OR changes lives." Thus fueling my strong sense of purpose and drives every strategy & launch I have developed. Feel free to connect to discuss commercialization of differentiated spine technology, building surgeon trust, innovation, outcomes, and/or the future of spine care. Let's connect and build our network!